SpironolactoneMineralocorticoid Receptor AntagonistsCanrenoneDiabetes Mellitus, Type 1Diabetes MellitusDiabetes Mellitus, Type 2AldosteroneHyperkalemiaCanrenoic AcidReceptors, MineralocorticoidDiureticsDiabetes ComplicationsDiabetes Mellitus, ExperimentalPregnadienesFludrocortisoneBendroflumethiazideDiabetes, GestationalHyperaldosteronismTriamtereneBlood GlucoseGynecomastiaMineralocorticoidsHemoglobin A, GlycosylatedHypoglycemic AgentsHeart FailureHypertensionInsulinPotassiumBlood PressureHypokalemiaRisk FactorsDiabetes InsipidusReninAngiotensin-Converting Enzyme InhibitorsSodium Chloride Symporter InhibitorsEndomyocardial FibrosisHirsutismDrug Therapy, CombinationDouble-Blind MethodChlorthalidoneMifepristoneHyperglycemiaAngiotensin II Type 1 Receptor BlockersTime FactorsHydrochlorothiazideTreatment OutcomeChlorothiazideDigoxinFibrosisMetolazoneRats, WistarFurosemide11-beta-Hydroxysteroid Dehydrogenase Type 2Glucose Tolerance TestDiabetic NephropathiesIslets of LangerhansAdrenalectomyProspective StudiesAntihypertensive AgentsPrediabetic StateDihydralazineDiabetic RetinopathyObesityInsulin ResistanceFollow-Up StudiesCross-Over StudiesVentricular RemodelingAlbuminuriaInsulin-Secreting CellsAmilorideProcollagenMice, Inbred NODSodium